ARCHIVES

FDA Advisors Uphold Broad Mandate To Limit Use Of ESA Products In Cancer Indications.

This article is from The Cancer Letter archive.

Vol. 33 No. 18 | May 11, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Schmidt Has Doubts About Community Saturation Program; Diane Fink Wins Gerard Lambert Award

July 25, 1975

Expert Review Of ImClone Protocol Concludes C225 Approval Unlikely.

February 15, 2002

Ethics Commission Remains Split On Compensation But Tells To Develop Pilot Program Proposal

May 15, 1981

P-32 Ingestion At NCI Attracts Attention; Similar Cases Seen At Labs In The Past

November 3, 1995

Micafungin Bests Fluconazole In Phase III Antifungal Trial

November 29, 2002

Schweiker Approves Chabner Appointment

September 10, 1982